Medical Communications

Showing 15 posts of 6408 posts found.

phone_health

Novartis forms a Pear to develop mobile therapies

March 2, 2018 Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical

Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
11149low_reception_in_darm

Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod

March 1, 2018 Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical

Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …
satu1028-pano_1024_px

EMA set to also revise guidelines of Alzheimer’s trials

February 28, 2018 Medical Communications Alzheimer's, EMA, FDA, biotech, drugs, pharma, pharmaceutical

The EMA, following on from the FDA’s lead earlier this month, has announced that it will revise its guidelines on …
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
nhs_sign

UK Government announces prescription price hike to record level

February 27, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …

Allergan’s patent gamble fails

February 27, 2018 Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical

Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …
opioid_crisis

FDA to fight opioid crisis with wider access to medication-assisted treatment

February 27, 2018 Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma

The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …
vaccination-2722937_960_720

UK govt report looks to reduce vaccination spending

February 27, 2018 Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical

One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …
nhs_trees

UK to crack down on 237m annual medication errors

February 23, 2018 Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

A new study commissioned by the Department of Health and Social Care has revealed that 237 million medication errors are …
tumour_growing_jan-chlebik-for-the-icr-2013

Lab-grown tumours able to predict drug efficacy

February 23, 2018 Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical

One of the key challenges facing the treatment of cancer is knowing whether a particular drug will work with an …

Novo Nordisk delivers in much-anticipated oral semaglutide diabetes trial

February 23, 2018 Medical Communications, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has lifted the curtain on much-anticipated results data from the first of ten Phase 3 trials into the …
gilead-sciences

Gilead seals $3bn deal, hoping for off-the-shelf CAR-T

February 23, 2018 Medical Communications, Sales and Marketing CAR-T, Gilead, Kite, Sangamo Therapeutics, biotech, drugs, pharma, pharmaceutical

The expense and laborious process involved in bringing CAR-T therapies to patients was used a key reason for the high …
The Gateway to Local Adoption Series

Latest content